Returns to R&D on new drug introductions in the 1980s
- 31 December 1994
- journal article
- review article
- Published by Elsevier BV in Journal of Health Economics
- Vol. 13 (4), 383-406
- https://doi.org/10.1016/0167-6296(94)90010-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug ActThe Journal of Law and Economics, 1992
- Profit Rates and Intangible CapitalThe Review of Economics and Statistics, 1991
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- A New Look at the Returns and Risks to Pharmaceutical R&DManagement Science, 1990
- A DYNAMIC ANALYSIS OF THE RESEARCH AND EXPERIMENTATION CREDITNational Tax Journal, 1988
- A closer look at the returns and risks of pharmaceutical R&DJournal of Health Economics, 1986
- Industrial Research and Development, Intangible Capital Stocks, and Firm Profit RatesThe Bell Journal of Economics, 1978
- The Measurement of Corporate Rates of Return: A Generalized FormationThe Bell Journal of Economics and Management Science, 1971